FDA Inspection 1258312 — Innovative Transfusion Medicine

Innovative Transfusion Medicine — FEI 3020588980

The FDA completed an inspection of Innovative Transfusion Medicine on Jan 7, 2025 in Deerfield Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 7, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Deerfield Beach, FL (United States)